First trimester maternal uterine artery Doppler examination in HIV-positive women

HIV Medicine

Volumn 12, Issue 10, 2011, Pages 632-636

  Savvidou, Md ^a,b   Samuel, M I ^b   Akolekar, R ^b   Poulton, M ^b   Nicolaides, K H ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Doppler examination; HIV; Pregnancy; Uterine artery

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL THERAPY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CASE CONTROL STUDY; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; CROWN RUMP LENGTH; DOPPLER FLOWMETRY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL HEIGHT; MATERNAL WEIGHT; MONOTHERAPY; NEGRO; PLACENTA; PRIORITY JOURNAL; PULSATILITY INDEX; RATING SCALE; UTERINE ARTERY; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; REVERSE TRANSCRIPTASE INHIBITORS; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY;

EID: 80054845147     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00930.x     Document Type: Article

References (20)

1. UNAIDS. 2008 Report on the global AIDS epidemic. Status of the global HIV epidemic. Available at (accessed 10 November 2010).
2. Health Protection Agency. HIV in the United Kingdom: 2009 Report. Available at (accessed 10 November 2010).
3. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008; 22: 973-981.
4. Wimalasundera RC, Larbalestier N, Smith JH et al. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002; 360: 1152-1154.
5. Suy A, Martínez E, Coll O et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 2006; 20: 59-66.
6. Boer K, Nellen JF, Patel D et al. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG 2007; 114: 148-155.
7. Mattar R, Amed AM, Lindsey PC, Sass N, Daher S. Preeclampsia and HIV infection. Eur J Obstet Gynecol Reprod Biol 2004; 117: 240-241.
8. Frank KA, Buchmann EJ, Schackis RC. Does human immunodeficiency virus infection protect against preeclampsia-eclampsia? Obstet Gynecol 2004; 104: 238-242.
9. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447-1451.
10. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 30: 742-749.
11. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late preeclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011; 31: 66-74.
12. Schillaci G, De Socio GV, Pucci G et al. Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension 2008; 52: 308-313.
13. Bonnet D, Aggoun Y, Szezepanski I, Bellal N, Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 2004; 18: 1037-1041.
14. Cammarosano C, Lewis W. Cardiac lesions in acquired immune deficiency syndrome (AIDS). J Am Coll Cardiol 1985; 5: 703-706.
15. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74: 1045-1052.
16. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk for trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998; 18: 519-521.
17. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008; 23: 1968-1975.
18. Kaplan RC, Kingsley LA, Gange SJ et al. Low CD4+T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008; 22: 1615-1624.
19. Hsue PY, Hunt PW, Sinclair E et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006; 20: 2275-2283.
20. Moffett A, Hiby SE. Immunological factors and placentation; implications for pre-eclampsia, In: Lyall F, Belfort M. eds. Pre-eclampsia Etiology and Clinical Practice, 1st edn. New York: Cambridge University Press, 2007, pp 92-102.